Hangzhou Clongene Biotech Co., Ltd.
Explore this company’s associated devices, FDA decisions and regulatory history.

Hangzhou Clongene Biotech Co., Ltd.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Hangzhou Clongene Biotech Co., Ltd.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 30, 2026 to Jan 30, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code GQG appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: #1 Yichuang Rd., Yuhang District, Hangzhou, 311121, CN. Recorded on K253318, decision dated Jan 30, 2026.
Device categories in this collection
Antigen, Cf (Including Cf Controls), Respiratory Syncytial Virus.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Clungene RSV Antigen Rapid Test
K253318 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.